SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-24-033669
Filing Date
2024-11-06
Accepted
2024-11-06 17:01:41
Documents
9
Period of Report
2024-12-02

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A pirs20240304_def14a.htm DEF 14A 464781
2 capg1.jpg GRAPHIC 86371
3 capvtsr.jpg GRAPHIC 64555
4 hijjisig.jpg GRAPHIC 4777
5 p01.jpg GRAPHIC 238480
6 p02.jpg GRAPHIC 367208
7 pirs20230119_def14aimg001.jpg GRAPHIC 3390
8 pirs20230119_def14aimg002.jpg GRAPHIC 2110
9 pirs20230119_def14aimg003.jpg GRAPHIC 2876
  Complete submission text file 0001437749-24-033669.txt   1526880
Mailing Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110
Business Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37471 | Film No.: 241432015
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)